Pawel Stocki

Pawel Stocki has extensive work experience in various scientific roles.

From 2003 to 2005, they worked as a Research Assistant at the University of Gdansk, where they focused on characterizing chaperone mediated protein disaggregation mechanisms. Pawel successfully established an in vitro fluorescence-based protein disaggregation model and depicted the roles of specific chaperones in the mechanism of protein disaggregation.

In 2004, they worked as a Research/Technician Assistant at the Max Planck Institute for Marine Microbiology.

From 2005 to 2009, they were a Research Associate at Newcastle University, studying the chaperone protein Hsp70 and its immunosuppressive role in regulating the immune system. This mechanism may have relevance in autoimmune diseases, transplantation, and cancer.

At the University of Toronto, from 2010 to 2012, they served as a Postdoctoral Research Associate, focusing on the prion protein and its role in neurodegenerative diseases. Pawel worked on a novel therapeutic strategy to reduce prion protein expression and studied the intrinsic redox cycle regulation mechanism in mammalian cells.

From 2013 to 2015, they worked as a Senior Scientist at Psynova Neurotech Ltd. Pawel led biomarker discovery and validation projects for various psychiatric disorders, with a focus on assay development and workflow automation.

In 2015, they joined MedImmune as a Scientist.

Currently, since 2015, they are working at Ossianix, starting as a Senior Scientist and progressing to Senior Principal Scientist and eventually becoming the Director of Research. Pawel is currently serving as the Vice President of Research.

Pawel Stocki began their education in 1999 at Uniwersytet Warmińsko-Mazurski w Olsztynie, where they studied Biology, General. Pawel completed their studies in 2000. Following this, they attended the University of Gdansk from 2000 to 2005, where they obtained a Master of Science (MSc) degree in Biotechnology. Finally, from 2005 to 2009, Pawel pursued their doctoral degree in Cellular Medicine at Newcastle University, earning a Doctor of Philosophy (Ph.D.).